Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever

NCT01088880 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Mediterranean Fever

Interventions

DRUG: Canakinumab

Sponsor

Novartis Pharmaceuticals